title: Inpatient or outpatient initiation of antiarrhythmic medications: why the controversy?
abstract: The decision of whether to initiate antiarrhythmic medications in or out of the hospital for patients with atrial fibrillation remains an issue of significant controversy. The current review analyzes the available data pertaining to the safety of antiarrhythmic agent initiation in patients with atrial fibrillation and provides a practice guideline.
authors.affiliation: Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. pzimetba@caregroup.harvard.edu
authors.forename: P
authors.initials: P
authors.lastname: Zimetbaum
authors.forename: D
authors.initials: D
authors.lastname: Pinto
authors.forename: M E
authors.initials: ME
authors.lastname: Josephson
mesh_terms: D000553:Ambulatory Care; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy; D003657:Decision Making; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007297:Inpatients; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents